DelSite Biotechnologies, Inc. Presents Nasal Powder and Synthetic Typhoid Vaccine Technologies at the 2nd Vaccines Asia Conference

Published: Nov 13, 2008

IRVING, TX--(Marketwire - November 13, 2008) - DelSite Inc., (OTCBB: DSII) today announced Dr. Yawei Ni, chief scientific officer, of its wholly-owned subsidiary, DelSite Biotechnologies, Inc., presented its innovative GelVacâ„¢ nasal powder platform for vaccine delivery and the synthetic typhoid vaccine at the 2nd Vaccines Asia Conference held November 10-13, 2008, in Beijing, China.

Back to news